These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 33569791)

  • 1. Skewed inflammation is associated with aberrant interleukin-37 signaling pathway in atopic dermatitis.
    Hou T; Tsang MS; Chu IM; Kan LL; Hon KL; Leung TF; Lam CW; Wong CK
    Allergy; 2021 Jul; 76(7):2102-2114. PubMed ID: 33569791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of IL-37 in Atopic Dermatitis.
    Mesjasz A; Trzeciak M; Gleń J; Jaskulak M
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential hub genes associated with atopic dermatitis-like recombinant human epidermal model using integrated transcriptomic and proteomic analysis.
    Qiao W; Xie T; Lu J; Jia T; Kaku K
    Biomol Biomed; 2024 Jan; 24(1):89-100. PubMed ID: 37540585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic characterization of atopic dermatitis blood from infancy to adulthood.
    Del Duca E; Renert-Yuval Y; Pavel AB; Mikhaylov D; Wu J; Lefferdink R; Fang M; Sheth A; Blumstein A; Facheris P; Estrada YD; Rangel SM; Krueger JG; Paller AS; Guttman-Yassky E
    J Am Acad Dermatol; 2023 May; 88(5):1083-1093. PubMed ID: 36773824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis.
    Napolitano M; di Vico F; Ruggiero A; Fabbrocini G; Patruno C
    Front Med (Lausanne); 2023; 10():1165098. PubMed ID: 37144036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus.
    Abuabara K; Nicholls SG; Langan SM; Guttman-Yassky E; Reynolds NJ; Paller AS; Brown SJ;
    Br J Dermatol; 2021 Jul; 185(1):203-205. PubMed ID: 33570761
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience.
    Simonetti O; Radi G; Diotallevi F; Molinelli E; Rizzetto G; Offidani A
    Clin Exp Dermatol; 2021 Jul; 46(5):939-940. PubMed ID: 33576497
    [No Abstract]   [Full Text] [Related]  

  • 8. Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5).
    Simpson EL; Forman S; Silverberg JI; Zirwas M; Maverakis E; Han G; Guttman-Yassky E; Marnell D; Bissonnette R; Waibel J; Nunes FP; DeLozier AM; Angle R; Gamalo M; Holzwarth K; Goldblum O; Zhong J; Janes J; Papp K
    J Am Acad Dermatol; 2021 Jul; 85(1):62-70. PubMed ID: 33600915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial.
    Nakatsuji T; Hata TR; Tong Y; Cheng JY; Shafiq F; Butcher AM; Salem SS; Brinton SL; Rudman Spergel AK; Johnson K; Jepson B; Calatroni A; David G; Ramirez-Gama M; Taylor P; Leung DYM; Gallo RL
    Nat Med; 2021 Apr; 27(4):700-709. PubMed ID: 33619370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis.
    Bakker DS; van der Wal MM; Heeb LEM; Giovannone B; Asamoah M; Delemarre EM; Drylewicz J; Nierkens S; Boyman O; de Bruin-Weller MS; Thijs JL; van Wijk F
    J Invest Dermatol; 2021 Aug; 141(8):1943-1953.e13. PubMed ID: 33610558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
    Marcant P; Balayé P; Merhi R; Jendoubi F; Nosbaum A; Raison-Peyron N; Du-Thanh A; Lasek A; Ferrier le Bouedec MC; Tetart F; Valois A; Barbarot S; Soria A; Jachiet M; Staumont-Sallé D;
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e394-e396. PubMed ID: 33594731
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolomic Analysis of Skin Biopsies from Patients with Atopic Dermatitis Reveals Hallmarks of Inflammation, Disrupted Barrier Function and Oxidative Stress.
    Ilves L; Ottas A; Kaldvee B; Abram K; Soomets U; Zilmer M; Jaks V; Kingo K
    Acta Derm Venereol; 2021 Feb; 101(2):adv00407. PubMed ID: 33585945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-31: The "itchy" cytokine in inflammation and therapy.
    Datsi A; Steinhoff M; Ahmad F; Alam M; Buddenkotte J
    Allergy; 2021 Oct; 76(10):2982-2997. PubMed ID: 33629401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review.
    Tier HL; Balogh EA; Bashyam AM; Fleischer AB; Spergel JM; Masicampo EJ; Kammrath LK; Strowd LC; Feldman SR
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):415-431. PubMed ID: 33599887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atopic Dermatitis: A Patient and Dermatologist's Perspective.
    Berruyer M; Delaunay J
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):347-353. PubMed ID: 33591542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.
    Thyssen JP; Vestergaard C; Barbarot S; de Bruin-Weller MS; Bieber T; Taieb A; Seneschal J; Cork MJ; Paul C; Flohr C; Weidinger S; Trzeciak M; Werfel T; Heratizadeh A; Darsow U; Simon D; Torrelo A; Chernyshov PV; Stalder JF; Gelmetti C; Szalai Z; Svensson Å; von Kobyletzki LB; De Raeve L; Fölster-Holst R; Christen-Zaech S; Hijnen DJ; Gieler U; Gutermuth J; Bangert C; Spuls PI; Kunz B; Ring J; Wollenberg A; Deleuran M
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):e308-e311. PubMed ID: 33587756
    [No Abstract]   [Full Text] [Related]  

  • 17. Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies.
    Forkel S; Cevik N; Schill T; Worm M; Mahler V; Weisshaar E; Vieluf D; Pfützner W; Löffler H; Schön MP; Geier J; Buhl T
    J Dtsch Dermatol Ges; 2021 Feb; 19(2):231-240. PubMed ID: 33586887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia Areata Related Paradoxical Reactions in Patients on Dupilumab Therapy: A Systematic Review.
    Sachdeva M; Witol A; Mufti A; Maliyar K; Yeung J
    J Cutan Med Surg; 2021; 25(4):451-452. PubMed ID: 33586473
    [No Abstract]   [Full Text] [Related]  

  • 19. A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence.
    Quadri M; Lotti R; Bonzano L; Ciardo S; Guanti MB; Pellacani G; Pincelli C; Marconi A
    Skin Pharmacol Physiol; 2021; 34(1):8-18. PubMed ID: 33601378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of baricitinib in prurigo-type atopic dermatitis: A case report.
    He Y; Ji S; Yu Q
    Dermatol Ther; 2021 Mar; 34(2):e14878. PubMed ID: 33583117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.